KU-177 is a potent inhibitor of Hsp90 ATPase homolog 1 (Aha1), capable of ablating Aha1-driven Hsp90-dependent tau aggregation enhancement; it disrupts the Aha1/Hsp90 interaction (IC50 = 4.08 μM) without affecting Hsp90’s ability to refold luciferase; it inhibits cancer cell growth and induces apoptosis, and is useful for the study of tauopathies.